W H de Jong - JoVE Visualize

Showing results (41-50 of 62) with videos related to

Pageof 7

Sort By:

Cancer Drug Delivery|January 1, 1987

Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumorG Storm, H J Van Gessel, P A Steerenberg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1989

Local interleukin-2 therapy in bovine ocular squamous cell carcinoma. A pilot studyV P Rutten, W R Klein, W A De Jong, et al.

Progress in Clinical and Biological Research|January 1, 1992

Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pigE C de Boer, P A Steerenberg, A P van der Meijden, et al.

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1988

Intravesical BCG administration in the guinea pig. A histomorphological studyA P van der Meijden, W H de Jong, P A Steerenberg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell wallsV P Rutten, W R Klein, W A De Jong, et al.

In Vivo (Athens, Greece)|November 1, 1991

Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-GuerinE C De Boer, W H De Jong, P A Steerenberg, et al.

Biochimica Et Biophysica Acta|April 12, 1995

Design of immunoliposomes directed against human ovarian carcinomaU K Nässander, P A Steerenberg, W H De Jong, et al.

Urological Research|January 1, 1986

The effects of intravesical and intradermal application of a new B.C.G. on the dog bladderA P vd Meijden, P A Steerenberg, W H de Jong, et al.

Urological Research|January 1, 1991

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysisE C de Boer, W H de Jong, A P van der Meijden, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1988

Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distributionP A Steerenberg, G Storm, G de Groot, et al.

Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:

Pageof 7

Cancer Drug Delivery|January 1, 1987

Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumorG Storm, H J Van Gessel, P A Steerenberg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1989

Local interleukin-2 therapy in bovine ocular squamous cell carcinoma. A pilot studyV P Rutten, W R Klein, W A De Jong, et al.

Progress in Clinical and Biological Research|January 1, 1992

Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pigE C de Boer, P A Steerenberg, A P van der Meijden, et al.

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1988

Intravesical BCG administration in the guinea pig. A histomorphological studyA P van der Meijden, W H de Jong, P A Steerenberg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell wallsV P Rutten, W R Klein, W A De Jong, et al.

In Vivo (Athens, Greece)|November 1, 1991

Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-GuerinE C De Boer, W H De Jong, P A Steerenberg, et al.

Biochimica Et Biophysica Acta|April 12, 1995

Design of immunoliposomes directed against human ovarian carcinomaU K Nässander, P A Steerenberg, W H De Jong, et al.

Urological Research|January 1, 1986

The effects of intravesical and intradermal application of a new B.C.G. on the dog bladderA P vd Meijden, P A Steerenberg, W H de Jong, et al.

Urological Research|January 1, 1991

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysisE C de Boer, W H de Jong, A P van der Meijden, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1988

Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distributionP A Steerenberg, G Storm, G de Groot, et al.

Pageof 7